Integrated DNA Technologies Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Integrated DNA Technologies Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10280
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Integrated DNA Technologies Inc (IDT) is a biotechnology company that develops diagnostic test products. The company’s products include DNA and RNA synthesis, genotyping, modifications, nextgen sequencing, gene silencing, synthesis genes, and purifications, among others. It offers services such as analytics, custom label, OEM, and packaging and formulation. IDT offers diagnostic tests for genetic and infectious diseases, research to discover new drugs and treatments, and producing agricultural products. The company offers solutions in areas of academic research, biotechnology, and pharmaceutical development. It has operations in Germany, Belgium, Singapore, the UK and the US. IDT is headquartered in Skokie, Illinois, the US.

Integrated DNA Technologies Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Integrated DNA Technologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Integrated DNA Technologies Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Integrated DNA Technologies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Integrated DNA Technologies Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Integrated DNA Technologies Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Integrated DNA Technologies Inc, Medical Equipment, Deal Details 10
Asset Purchase 10
Integrated DNA Technologies Acquires Rights to Surveyor Mutation Detection Technology and Assets from Transgenomic for up to USD4.25 Million 10
Integrated DNA Technologies Acquires Oligonucleotide Business From 1st BASE 12
Private Equity 13
Summit Partners Acquires Minority Stake In Integrated DNA Technologies 13
Partnerships 14
Integrated DNA Enters into Licensing Agreement with EliTech 14
Takara Bio Enters into Agreement with Integrated DNA Technologies 15
Sophia Genetics Enters into Agreement with Integrated DNA 16
Integrated DNA Enters into Co-Development Agreement with Ubiquitome 17
RainDance Technologies Enters Into Co-Development Agreement With Integrated DNA Technologies For Digital PCR 18
WaferGen Biosystems Enters Into Agreement With Integrated DNA Technologies 19
Acquisition 20
Danaher to Acquire Integrated DNA Technologies 20
Integrated DNA Technologies Inc – Key Competitors 21
Integrated DNA Technologies Inc – Key Employees 22
Integrated DNA Technologies Inc – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Product News 24
Jun 15, 2017: IDT raises the bar for PCR-based genotyping with novel rhAmp SNP solution 24
Feb 01, 2017: IDT first to market with complete Cpf1-based CRISPR genome editing system 25
Other Significant Developments 26
May 02, 2017: Integrated DNA Technologies appoints LubioScience as distributors in Switzerland 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Integrated DNA Technologies Inc, Medical Equipment, Key Facts 2
Integrated DNA Technologies Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Integrated DNA Technologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Integrated DNA Technologies Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Integrated DNA Technologies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Integrated DNA Technologies Inc, Deals By Market, 2012 to YTD 2018 8
Integrated DNA Technologies Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Integrated DNA Technologies Acquires Rights to Surveyor Mutation Detection Technology and Assets from Transgenomic for up to USD4.25 Million 10
Integrated DNA Technologies Acquires Oligonucleotide Business From 1st BASE 12
Summit Partners Acquires Minority Stake In Integrated DNA Technologies 13
Integrated DNA Enters into Licensing Agreement with EliTech 14
Takara Bio Enters into Agreement with Integrated DNA Technologies 15
Sophia Genetics Enters into Agreement with Integrated DNA 16
Integrated DNA Enters into Co-Development Agreement with Ubiquitome 17
RainDance Technologies Enters Into Co-Development Agreement With Integrated DNA Technologies For Digital PCR 18
WaferGen Biosystems Enters Into Agreement With Integrated DNA Technologies 19
Danaher to Acquire Integrated DNA Technologies 20
Integrated DNA Technologies Inc, Key Competitors 21
Integrated DNA Technologies Inc, Key Employees 22
Integrated DNA Technologies Inc, Other Locations 23
Integrated DNA Technologies Inc, Subsidiaries 23

List of Figures
Integrated DNA Technologies Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Integrated DNA Technologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Integrated DNA Technologies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Integrated DNA Technologies Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Integrated DNA Technologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Integrated DNA Technologies Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Integrated DNA Technologies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Integrated DNA Technologies Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Integrated DNA Technologies Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • GelTech Solutions Inc (GLTC):企業の財務・戦略的SWOT分析
    Summary GelTech Solutions Inc (GelTech Solutions) is a chemical solutions company that manufactures and markets environmentally-friendly chemicals and fire prevention and suppression products. It offers products such as fireice shield and soil2O. Its fireice shield is a fire suppression product that …
  • Bioverativ Inc (BIVV):医療機器:M&Aディール及び事業提携情報
    Summary Bioverativ Inc (Bioverativ) is a biotechnology company that discovers, develops, and markets therapeutics for the treatment of hemophilia, and rare blood disorders. Its product portfolio includes Eloctate, which comprises recombinant antihemophilic factor engineered using Fc fusion technolog …
  • BioGaia AB (BIOG B)-製薬・医療分野:企業M&A・提携分析
    Summary BioGaia AB (BioGaia) is a biopharmaceutical company, which develops, markets and sells probiotic products. The company sells its probiotic food supplements and oral health products in various dosage forms including drops, lozenges, tablets, chewable tablets, oral rehydration salts (ORS), str …
  • Pathway Genomics Corp-医療機器分野:企業M&A・提携分析
    Summary Pathway Genomics Corp (Pathway Genomics) is a healthcare laboratory that offers genetic testing services to physicians and their patients with actionable and accurate precision healthcare information to improve health and wellness. Its tests comprise liquid biopsy cancer intercept, true here …
  • China Power Clean Energy Development Co Ltd (0735):企業の財務・戦略的SWOT分析
    China Power Clean Energy Development Co Ltd (0735) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Chenguang Biotech Group Co Ltd (300138):企業の財務・戦略的SWOT分析
    Chenguang Biotech Group Co Ltd (300138) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • United Therapeutics Corp (UTHR):医療機器:M&Aディール及び事業提携情報
    Summary United Therapeutics Corp (UTC) develops and commercializes innovative pharmaceutical products for the treatment of cardiovascular disorders, particularly pulmonary arterial hypertension and infectious diseases. The company's products consist of prostacyclin analogues including Remodulin (tre …
  • Grendene S.A. (GRND3):企業の財務・戦略的SWOT分析
    Grendene S.A. (GRND3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Astrotech Corporation:企業の戦略・SWOT・財務分析
    Astrotech Corporation - Strategy, SWOT and Corporate Finance Report Summary Astrotech Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Pioneer Corp:企業の戦略的SWOT分析
    Pioneer Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Ichor Holdings Ltd (ICHR):企業の財務・戦略的SWOT分析
    Ichor Holdings Ltd (ICHR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • West Hertfordshire Hospitals NHS Trust:企業の戦略的SWOT分析
    West Hertfordshire Hospitals NHS Trust - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Titanium Metals Corporation:企業の戦略・SWOT・財務情報
    Titanium Metals Corporation - Strategy, SWOT and Corporate Finance Report Summary Titanium Metals Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Petroleos Mexicanos:企業の戦略・SWOT・財務情報
    Petroleos Mexicanos - Strategy, SWOT and Corporate Finance Report Summary Petroleos Mexicanos - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • DxTerity Diagnostics Inc-医療機器分野:企業M&A・提携分析
    Summary DxTerity Diagnostics Inc (DxTerity) is a medical device company that offers molecular diagnostic solutions. The company develops genomic tests for disease diagnosis and monitoring in its genomics laboratory. The company’s patient clinical research platform and dxcollect fingerstick collectio …
  • Faxitron Bioptics LLC:医療機器:M&Aディール及び事業提携情報
    Summary Faxitron Bioptics LLC (Faxitron) is a medical device company that develops cabinet x-ray systems for specimen radiography, research and NDT applications. The company offers clinical products and lifescience products. Its clinical products include pathvision, corevision, biovision, localizer, …
  • Electric Power Development Co Ltd (9513):企業の財務・戦略的SWOT分析
    Electric Power Development Co Ltd (9513) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Neoleukin Therapeutics Inc (NLTX):企業の財務・戦略的SWOT分析
    Summary Neoleukin Therapeutics Inc (Neoleukin), formely Aquinox Pharmaceuticals Inc is a biopharmaceutical company develops next generation immunotherapies to treat immunological disorders. The company's lead drug candidate NL-201 is a combined IL-2 and IL-15 protein therapeutic used as an agonist i …
  • Abu Dhabi Commercial Bank P.J.S.C.:企業の戦略・SWOT・財務情報
    Abu Dhabi Commercial Bank P.J.S.C. - Strategy, SWOT and Corporate Finance Report Summary Abu Dhabi Commercial Bank P.J.S.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Nucor Corporation:企業のM&A・事業提携・投資動向
    Nucor Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Nucor Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆